CARE TO CARE LICENSED BEHAVIOR ANALYST PC – Trademark Portfolio

Entity Type: 99

CARE TO CARE LICENSED BEHAVIOR ANALYST PC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include DOUBLE CARE and DOUBLE CARE ABA. The owner is based in BROOKLYN, NY.

223 BEDFORD AVENUE

SUITE A #2044

BROOKLYN, NY 11211

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CARE TO CARE LICENSED BEHAVIOR ANALYST PC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does CARE TO CARE LICENSED BEHAVIOR ANALYST PC have?

CARE TO CARE LICENSED BEHAVIOR ANALYST PC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does CARE TO CARE LICENSED BEHAVIOR ANALYST PC file in?

CARE TO CARE LICENSED BEHAVIOR ANALYST PC files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are CARE TO CARE LICENSED BEHAVIOR ANALYST PC's most well-known trademarks?

CARE TO CARE LICENSED BEHAVIOR ANALYST PC's registered trademark portfolio includes well-known marks such as DOUBLE CARE and DOUBLE CARE ABA. These are among 2 currently registered trademarks in the portfolio.

What is CARE TO CARE LICENSED BEHAVIOR ANALYST PC's trademark registration success rate?

CARE TO CARE LICENSED BEHAVIOR ANALYST PC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.